Cargando…
The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatme...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137314/ https://www.ncbi.nlm.nih.gov/pubmed/12398771 |
_version_ | 1782120429655162880 |
---|---|
author | Bernard, Gordon |
author_facet | Bernard, Gordon |
author_sort | Bernard, Gordon |
collection | PubMed |
description | Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatment of this major clinical problem remains elusive. Recently, interest has resurfaced but this time the focus is on a steroid replacement approach for what has now been termed "relative adrenal insufficiency" rather than relying on the pharmacologic effects of steroids. This route holds promise, but proof remains lacking. |
format | Text |
id | pubmed-137314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1373142003-02-27 The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock Bernard, Gordon Crit Care Commentary Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatment of this major clinical problem remains elusive. Recently, interest has resurfaced but this time the focus is on a steroid replacement approach for what has now been termed "relative adrenal insufficiency" rather than relying on the pharmacologic effects of steroids. This route holds promise, but proof remains lacking. BioMed Central 2002 2002-07-17 /pmc/articles/PMC137314/ /pubmed/12398771 Text en |
spellingShingle | Commentary Bernard, Gordon The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title | The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title_full | The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title_fullStr | The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title_full_unstemmed | The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title_short | The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
title_sort | international sepsis forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137314/ https://www.ncbi.nlm.nih.gov/pubmed/12398771 |
work_keys_str_mv | AT bernardgordon theinternationalsepsisforumscontroversiesinsepsiscorticosteroidsshouldnotberoutinelyusedtotreatsepticshock AT bernardgordon internationalsepsisforumscontroversiesinsepsiscorticosteroidsshouldnotberoutinelyusedtotreatsepticshock |